Lentiviral vectors (LVs) are crucial tools in gene therapy and bioproduction, but high-yield LV production systems are urgently needed. Using clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 9 high-throughput screening, we identified nine critical genes (LDAH, GBP3, BPIFC, NHLRC1, NHLRC3, ZNF425, TTC37, LRRC4B, and SPINK6) from 17,501 genes that limit LV packaging and formation. Knocking out these genes in HEK293T cells significantly increased virus production, with LDAH knockout exhibiting a 6.63-fold increase. Studies on multigene knockouts demonstrated that the cumulative effects of different gene knockouts can significantly enhance lentivirus production in HEK293T cells. Triple knockout of GBP3, BPIFC, and LDAH increased LV titer by ∼8.33-fold, and knockout (or knockdown) of GBP3, NHLRC1, and NHLRC3 increased LV titer by ∼6.53-fold. This study established HEK293T cell lines with multiple genes knockout for efficient LV production, providing reliable technical support for LV production and application and offering new perspectives for studying LV packaging mechanisms and related virus research.
Get full access to this article
View all access options for this article.
References
1.
LewisP, HenselM, EmermanM. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J, 1992; 11(8):3053–3058; doi: 10.1002/j.1460-2075.1992.tb05376.x
2.
MorganRA, UntiMJ, AlesheB, et al.Improved titer and gene transfer by lentiviral vectors using novel, Small β-Globin locus control region elements. Mol Ther, 2020; 28(1):328–340; doi: 10.1016/j.ymthe.2019.09.020
3.
MorganRA, MaF, UntiMJ, et al.Creating new β-globin-expressing lentiviral vectors by high-resolution mapping of locus control region enhancer sequences. Mol Ther Methods Clin Dev, 2020; 17:999–1013; doi: 10.1016/j.omtm.2020.04.006
4.
KohnDB, BoothC, ShawKL, et al.Autologous ex vivo lentiviral gene therapy for adenosine deaminase deficiency. N Engl J Med, 2021; 384(21):2002–2013; doi: 10.1056/NEJMoa2027675
5.
HannaE, RémuzatC, AuquierP, et al.Advanced therapy medicinal products: Current and future perspectives. J Mark Access Health Policy, 2016; 4(1):31036; doi: 10.3402/jmahp.v4.31036
6.
NoblesCL, Sherrill-MixS, EverettJK, et al.CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration. The Journal of Clinical Investigation, 2020; 130(2):673–685; doi: 10.1172/jci130144
7.
LabischJJ, WieseGP, BarnesK, et al.Infectious titer determination of lentiviral vectors using a temporal immunological real-time imaging approach. PLoS One, 2021; 16(7):e0254739; doi: 10.1371/journal.pone.0254739
8.
ZhengPP, KrosJM, LiJ. Approved CAR T cell therapies: Ice bucket challenges on glaring safety risks and long-term impacts. Drug Discov Today, 2018; 23(6):1175–1182; doi: 10.1016/j.drudis.2018.02.012
9.
AmiracheF, LévyC, CostaC, et al.Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood, 2014; 123(9):1422–1424; doi: 10.1182/blood-2013-11-540641
10.
EslahiNK, MullerS, NguyenL, et al.Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy. Cancer Gene Ther, 2001; 8(1):55–62; doi: 10.1038/sj.cgt.7700270
DullT, ZuffereyR, KellyM, et al.A third-generation lentivirus vector with a conditional packaging system. J Virol, 1998; 72(11):8463–8471; doi: 10.1128/jvi.72.11.8463-8471.1998
13.
SeguraMM, MangionM, GailletB, et al.New developments in lentiviral vector design, production, and purification. Expert Opin Biol Ther, 2013; 13(7):987–1011; doi: 10.1517/14712598.2013.779249
14.
WoodsMW, TongJG, TomSK, et al.Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export. Retrovirology, 2014; 11:27; doi: 10.1186/1742-4690-11-27
15.
FuenmayorJ, CerveraL, RigauC, et al.Enhancement of HIV-1 VLP production using gene inhibition strategies. Appl Microbiol Biotechnol, 2018; 102(10):4477–4487; doi: 10.1007/s00253-018-8930-8
16.
HanJ, TamK, TamC, et al.Improved lentiviral vector titers from a multi-gene knockout packaging line. Mol Ther Oncolytics, 2021; 23:582–592; doi: 10.1016/j.omto.2021.11.012
17.
IaffaldanoBJ, MarinoMP, ReiserJ. CRISPR library screening to develop HEK293-derived cell lines with improved lentiviral vector titers. Front Genome Ed, 2023; 5:1218328; doi: 10.3389/fgeed.2023.1218328
18.
XuP, LiuZ, LiuY, et al.Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs. Nat Biotechnol, 2021; 39(11):1403–1413; doi: 10.1038/s41587-021-00944-1
19.
SulemanS, PayneA, BowdenJ, et al.HIV-1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival. Gene Ther, 2022; 29(12):720–729; doi: 10.1038/s41434-022-00335-4
20.
NordmannA, WixlerL, BoergelingY, et al.A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. Faseb J, 2012; 26(3):1290–1300; doi: 10.1096/fj.11-189886
ZhuB, MandalSS, PhamAD, et al.The human PAF complex coordinates transcription with events downstream of RNA synthesis. Genes Dev, 2005; 19(14):1668–1673; doi: 10.1101/gad.1292105
23.
ZinovievA, AyupovRK, AbaevaIS, et al.Extraction of mRNA from stalled ribosomes by the ski complex. Mol Cell, 2020; 77(6):1340–1349.e6; doi: 10.1016/j.molcel.2020.01.011
24.
KögelA, KeidelA, BonneauF, et al.The human SKI complex regulates channeling of ribosome-bound RNA to the exosome via an intrinsic gatekeeping mechanism. Molecular Cell, 2022; 82(4):756–769.e8; doi: 10.1016/j.molcel.2022.01.009
Gouvarchin GhalehHE, BolandianM, DorostkarR, et al.Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy. Biomed Pharmacother, 2020; 128:110276; doi: 10.1016/j.biopha.2020.110276
27.
FonsecaGJ, ThillainadesanG, YousefAF, et al.Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe, 2012; 11(6):597–606; doi: 10.1016/j.chom.2012.05.005
28.
SanjanaNE, ShalemO, ZhangF. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods, 2014; 11(8):783–784; doi: 10.1038/nmeth.3047
29.
WangQ, ZhangX, HanY, et al.M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner. Sci Rep, 2016; 6(1):32736; doi: 10.1038/srep32736
30.
WilsonSJ, SchogginsJW, ZangT, et al.Inhibition of HIV-1 particle assembly by 2’,3’-cyclic-nucleotide 3’-phosphodiesterase. Cell Host Microbe, 2012; 12(4):585–597; doi: 10.1016/j.chom.2012.08.012
31.
CurrallBB, ChenM, SallariRC, et al.Loss of LDAH associated with prostate cancer and hearing loss. Hum Mol Genet, 2018; 27(24):4194–4203; doi: 10.1093/hmg/ddy310
32.
XuH, JinJ, ChenY, et al.GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. Oncogene, 2022; 41(31):3876–3885; doi: 10.1038/s41388-022-02397-5
33.
WhiteDR, KhedriZ, KiptooP, et al.Synthesis of a Bifunctional Peptide Inhibitor-IgG1 Fc fusion that suppresses experimental autoimmune encephalomyelitis. Bioconjug Chem, 2017; 28(7):1867–1877; doi: 10.1021/acs.bioconjchem.7b00175
34.
MavromatisLA, RosoffDB, BellAS, et al.Multi-omic underpinnings of epigenetic aging and human longevity. Nat Commun, 2023; 14(1):2236; doi: 10.1038/s41467-023-37729-w
35.
YangL, YangT, WangH, et al.DNMBP-AS1 Regulates NHLRC3 expression by sponging miR-93-5p/17-5p to inhibit colon cancer progression. Front Oncol, 2022; 12:765163; doi: 10.3389/fonc.2022.765163
36.
WangY, YeX, ZhouJ, et al.A novel human KRAB-related zinc finger gene ZNF425 inhibits mitogen-activated protein kinase signaling pathway. BMB Reports, 2011; 44(1):58–63; doi: 10.5483/BMBRep.2011.44.1.58
37.
BourgeoisP, EsteveC, ChaixC, et al.THES clinical consortium. Tricho-Hepato-Enteric Syndrome mutation update: Mutations spectrum of TTC37 and SKIV2L, clinical analysis and future prospects. Hum Mutat, 2018; 39(6):774–789; doi: 10.1002/humu.23418
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
